We also have identified that SHCBP1 may be indispensable for the stem cell-like phenotype driven by EGF-β-catenin signaling and is up-regulated in NSCLC and other cancers in a manner correlated with unfavorable clinical prognosis of the disease. Here, SHCBP1 is linked to non-small cell lung carcinoma.